Angels and demons: Th17 cells represent a beneficial response, while neutrophil IL-17 is associated with poor prognosis in squamous cervical cancer

OncoImmunology

Volumn 4, Issue 1, 2015, Pages 984539-

  Punt, Simone ^a   Fleuren, Gert Jan ^a   Kritikou, Eva ^a   Lubberts, Erik ^b   Trimbos, J Baptist ^a   Jordanova, Ekaterina S ^a   Gorter, Arko ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

IL 17; neutrophil; Th17; tumor microenvironment; uterine cervical cancer

Indexed keywords

INTERLEUKIN 17;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; FOLLOW UP; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNE RESPONSE; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; NEUTROPHIL; TH17 CELL; TUMOR GROWTH; UTERINE CERVIX CANCER;

EID: 84926647283     PISSN: 21624011     EISSN: 2162402X     Source Type: Journal    
DOI: 10.4161/2162402X.2014.984539     Document Type: Article

References (49)

1. R.Siegel, J.Ma, Z.Zou, A.Jemal. Cancer statistics, 2014. CA Cancer J Clin 2014; 64:9-29; PMID:24399786; dx.doi.org/10.3322/caac.21208
2. J.M.Walboomers, M.V.Jacobs, M.M.Manos, F.X.Bosch, J.A.Kummer, K.V.Shah, P.J.Snijders, J.Peto, C.J.Meijer, N.Munoz. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999; 189:12-19; PMID:10451482; dx.doi.org/10.1002/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F
3. F.Balkwill, A.Mantovani. Inflammation and cancer: back to Virchow? Lancet 2001; 357:539-45; PMID:11229684; dx.doi.org/10.1016/S0140-6736(00)04046-0
4. L.A.Koopman, W.E.Corver, A.R.van der Slik, M.J.Giphart, G.J.Fleuren. Multiple genetic alterations cause frequent and heterogeneous human histocompatibility leukocyte antigen class I loss in cervical cancer. J Exp Med 2000; 191:961-76; PMID:10727458; dx.doi.org/10.1084/jem.191.6.961
5. T.J.Stewart, S.I.Abrams. How tumours escape mass destruction. Oncogene 2008; 27:5894-903; PMID:18836470; dx.doi.org/10.1038/onc.2008.268
6. J.L.Langowski, R.A.Kastelein, M.Oft. Swords into plowshares: IL-23 repurposes tumor immune surveillance. Trends Immunol 2007; 28:207-12; PMID:17395538; dx.doi.org/10.1016/j.it.2007.03.006
7. A.Mantovani. Cancer: Inflaming metastasis. Nature 2009; 457:36-37; PMID:19122629; dx.doi.org/10.1038/457036b
8. H.J.Zijlmans, S.Punt, G.J.Fleuren, J.B.Trimbos, G.G.Kenter, A.Gorter. Role of IL-12p40 in cervical carcinoma. Br J Cancer 2012; 107:1956-62; PMID:23099807; dx.doi.org/10.1038/bjc.2012.488
9. T.Shalom-Barak, J.Quach, M.Lotz. Interleukin-17-induced gene expression in articular chondrocytes is associated with activation of mitogen-activated protein kinases and NF-kappab. J Biol Chem 1998; 273:27467-73; PMID:9765276; dx.doi.org/10.1074/jbc.273.42.27467
10. M.Numasaki, J.Fukushi, M.Ono, S.K.Narula, P.J.Zavodny, T.Kudo, P.D.Robbins, H.Tahara, M.T.Lotze. Interleukin-17 promotes angiogenesis and tumor growth. Blood 2003; 101:2620-7; PMID:12411307; dx.doi.org/10.1182/blood-2002-05-1461
11. M.Numasaki, M.T.Lotze, H.Sasaki. Interleukin-17 augments tumor necrosis factor-alpha-induced elaboration of proangiogenic factors from fibroblasts. Immunol Lett 2004; 93:39-43; PMID:15134897; dx.doi.org/10.1016/j.imlet.2004.01.014
12. M.C.Honorati, S.Neri, L.Cattini, A.Facchini. Interleukin-17, a regulator of angiogenic factor release by synovial fibroblasts. Osteoarthr Cartilage 2006; 14:345-52; PMID:16311048; dx.doi.org/10.1016/j.joca.2005.10.004
13. J.Liu, Y.Duan, X.Cheng, X.Chen, W.Xie, H.Long, Z.Lin, B.Zhu. IL-17 is associated with poor prognosis and promotes angiogenesis via stimulating VEGF production of cancer cells in colorectal carcinoma. Biochem Biophys Res Commun 2011; 407:348-54; PMID:21396350; dx.doi.org/10.1016/j.bbrc.2011.03.021
14. X.Chen, J.Wan, J.Liu, W.Xie, X.Diao, J.Xu, B.Zhu, Z.Chen. Increased IL-17-producing cells correlate with poor survival and lymphangiogenesis in NSCLC patients. Lung Cancer 2010; 69:348-54; PMID:20022135; dx.doi.org/10.1016/j.lungcan.2009.11.013
15. M.Kawaguchi, F.Kokubu, H.Kuga, S.Matsukura, H.Hoshino, K.Ieki, T.Imai, M.Adachi, S.K.Huang. Modulation of bronchial epithelial cells by IL-17. J Allergy Clin Immunol 2001; 108:804-9; PMID:11692108; dx.doi.org/10.1067/mai.2001.119027
16. M.Laan, Z.H.Cui, H.Hoshino, J.Lotvall, M.Sjostrand, D.C.Gruenert, B.E.Skoogh, A.Linden. Neutrophil recruitment by human IL-17 via C-X-C chemokine release in the airways. J Immunol 1999; 162:2347-52; PMID:9973514
17. T.Kinugasa, T.Sakaguchi, X.Gu, H.C.Reinecker. Claudins regulate the intestinal barrier in response to immune mediators. Gastroenterology 2000; 118:1001-11; PMID:10833473; dx.doi.org/10.1016/S0016-5085(00)70351-9
18. H.A.Alshaker, K.Z.Matalka. IFN-gamma, IL-17 and TGF-beta involvement in shaping the tumor microenvironment: The significance of modulating such cytokines in treating malignant solid tumors. Cancer Cell Int 2011; 11:33; PMID:21943203; dx.doi.org/10.1186/1475-2867-11-33
19. J.Ye, R.S.Livergood, G.Peng. The role and regulation of human Th17 cells in tumor immunity. Am J Pathol 2013; 182:10-20; PMID:23159950; dx.doi.org/10.1016/j.ajpath.2012.08.041
20. G.Murugaiyan, B.Saha. Protumor vs antitumor functions of IL-17. J Immunol 2009; 183:4169-75; PMID:19767566; dx.doi.org/10.4049/jimmunol.0901017
21. D.J.Cua, C.M.Tato. Innate IL-17-producing cells: the sentinels of the immune system. Nat Rev Immunol 2010; 10:479-89; PMID:20559326; dx.doi.org/10.1038/nri2800
22. K.Hirota, H.Ahlfors, J.H.Duarte, B.Stockinger. Regulation and function of innate and adaptive interleukin-17-producing cells. EMBO Rep 2012; 13:113-20; PMID:22193778; dx.doi.org/10.1038/embor.2011.248
23. E.M.Moran, R.Heydrich, C.T.Ng, T.P.Saber, J.mccormick, J.Sieper, H.Appel, U.Fearon, D.J.Veale. IL-17A expression is localised to both mononuclear and polymorphonuclear synovial cell infiltrates. PloS One 2011; 6:e24048; PMID:21887369; dx.doi.org/10.1371/journal.pone.0024048
24. A.M.Lin, C.J.Rubin, R.Khandpur, J.Y.Wang, M.Riblett, S.Yalavarthi, E.C.Villanueva, P.Shah, M.J.Kaplan, A.T.Bruce. Mast cells and neutrophils release IL-17 through extracellular trap formation in psoriasis. J Immunol 2011; 187:490-500; PMID:21606249; dx.doi.org/10.4049/jimmunol.1100123
25. A.Eustace, L.J.Smyth, L.Mitchell, K.Williamson, J.Plumb, D.Singh. Identification of cells expressing IL-17A and IL-17F in the lungs of patients with COPD. Chest 2011; 139:1089-100; PMID:20864612; dx.doi.org/10.1378/chest.10-0779
26. C.Lan, X.Huang, S.Lin, H.Huang, Q.Cai, J.Lu, J.Liu. High density of IL-17-producing cells is associated with improved prognosis for advanced epithelial ovarian cancer. Cell Tissue Res 2013; 352:351-9; PMID:23397428; dx.doi.org/10.1007/s00441-013-1567-0
27. J.B.Cowland, N.Borregaard. The individual regulation of granule protein mrna levels during neutrophil maturation explains the heterogeneity of neutrophil granules. J Leukoc Biol 1999; 66:989-95; PMID:10614782
28. N.Borregaard, K.Theilgaard-Monch, O.E.Sorensen, J.B.Cowland. Regulation of human neutrophil granule protein expression. Curr Opin Hematol 2001; 8:23-7; PMID:11138622; dx.doi.org/10.1097/00062752-200101000-00005
29. B.Wang, L.Li, Y.Liao, J.Li, X.Yu, Y.Zhang, J.Xu, H.Rao, S.Chen, L.Zhang Mast cells expressing interleukin 17 in the muscularis propria predict a favorable prognosis in esophageal squamous cell carcinoma. Cancer Immunol Immunother 2013; 62:1575-85: PMID:23912243; dx.doi.org/10.1007/s00262-013-1460-4
30. J.P.Zhang, J.Yan, J.Xu, X.H.Pang, M.S.Chen, L.Li, C.Wu, S.P.Li, L.Zheng. Increased intratumoral IL-17-producing cells correlate with poor survival in hepatocellular carcinoma patients. J Hepatol 2009; 50:980-9; PMID:19329213; dx.doi.org/10.1016/j.jhep.2008.12.033
31. K.S.Sfanos, T.C.Bruno, C.H.Maris, L.Xu, C.J.Thoburn, A.M.demarzo, A.K.Meeker, W.B.Isaacs, C.G.Drake. Phenotypic analysis of prostate-infiltrating lymphocytes reveals TH17 and Treg skewing. Clin Cancer Res 2008; 14:3254-61; PMID:18519750; dx.doi.org/10.1158/1078-0432.CCR-07-5164
32. Z.J.Ye, Q.Zhou, Y.Y.Gu, S.M.Qin, W.L.Ma, J.B.Xin, X.N.Tao, H.Z.Shi. Generation and differentiation of IL-17-producing CD4+ T cells in malignant pleural effusion. J Immunol 2010; 185:6348-54; PMID:20952674; dx.doi.org/10.4049/jimmunol.1001728
33. E.Tartour, F.Fossiez, I.Joyeux, A.Galinha, A.Gey, E.Claret, X.Sastre-Garau, J.Couturier, V.Mosseri, V.Vives Interleukin 17, a T-cell-derived cytokine, promotes tumorigenicity of human cervical tumors in nude mice. Cancer Res 1999; 59:3698-704; PMID:10446984
34. T.Lai, K.Wang, Q.Hou, J.Zhang, J.Yuan, L.Yuan, Z.You, M.Xi. Interleukin 17 induces up-regulation of chemokine and cytokine expression via activation of the nuclear factor kappab and extracellular signal-regulated kinase 1/2 pathways in gynecologic cancer cell lines. Int. J. Gynecol. Cancer 2011; 21:1533-9; PMID:21912264; dx.doi.org/10.1097/IGC.0b013e31822d2abd
35. L.L.Cunha, E.C.Morari, A.C.Guihen, D.Razolli, R.Gerhard, S.Nonogaki, F.A.Soares, J.Vassallo, L.S.Ward. Infiltration of a mixture of immune cells may be related to good prognosis in patients with differentiated thyroid carcinoma. Clin Endocrinol (Oxf) 2012; 77:918-25; PMID:22738343; dx.doi.org/10.1111/j.1365-2265.2012.04482.x
36. A.D.Gregory, A.M.Houghton. Tumor-associated neutrophils:new targets for cancer therapy. Cancer Res 2011; 71:2411-6; PMID:21427354; dx.doi.org/10.1158/0008-5472.CAN-10-2583
37. D.M.Kuang, Q.Zhao, Y.Wu, C.Peng, J.Wang, Z.Xu, X.Y.Yin, L.Zheng. Peritumoral neutrophils link inflammatory response to disease progression by fostering angiogenesis in hepatocellular carcinoma. J Hepatol 2011; 54:948-55; PMID:21145847; dx.doi.org/10.1016/j.jhep.2010.08.041
38. M.Pelletier, L.Maggi, A.Micheletti, E.Lazzeri, N.Tamassia, C.Costantini, L.Cosmi, C.Lunardi, F.Annunziato, S.Romagnani Evidence for a cross-talk between human neutrophils and Th17 cells. Blood 2010; 115:335-43; PMID:19890092; dx.doi.org/10.1182/blood-2009-04-216085
39. L.Li, L.Huang, A.L.Vergis, H.Ye, A.Bajwa, V.Narayan, R.M.Strieter, D.L.Rosin, M.D.Okusa. IL-17 produced by neutrophils regulates IFN-gamma-mediated neutrophil migration in mouse kidney ischemia-reperfusion injury. J Clin Invest 2010; 120:331-42; PMID:20038794; dx.doi.org/10.1172/JCI38702
40. Z.Tan, R.Jiang, X.Wang, Y.Wang, L.Lu, Q.Liu, S.G.Zheng, B.Sun, B.Ryffel. Rorgammat+IL-17+ neutrophils play a critical role in hepatic ischemia-reperfusion injury. J Mol Cell Biol 2013; 5:143-6; PMID:23362310; dx.doi.org/10.1093/jmcb/mjs065
41. D.Utrera-Barillas, M.Castro-Manrreza, E.Castellanos, M.Gutierrez-Rodriguez, E.O.Arciniega-Ruiz de, J.Garcia-Cebada, J.R.Velazquez, D.Flores-Resendiz, D.Hernandez-Hernandez, L.Benitez-Bribiesca. The role of macrophages and mast cells in lymphangiogenesis and angiogenesis in cervical carcinogenesis. Exp Mol Pathol 2010; 89:190-6; PMID:20599941; dx.doi.org/10.1016/j.yexmp.2010.06.002
42. A.Johansson, S.Rudolfsson, P.Hammarsten, S.Halin, K.Pietras, J.Jones, P.Stattin, L.Egevad, T.Granfors, P.Wikstrom Mast cells are novel independent prognostic markers in prostate cancer and represent a target for therapy. Am J Pathol 2010; 177:1031-41; PMID:20616342; dx.doi.org/10.2353/ajpath.2010.100070
43. A.B.Rajput, D.A.Turbin, M.C.Cheang, D.K.Voduc, S.Leung, K.A.Gelmon, C.B.Gilks, D.G.Huntsman. Stromal mast cells in invasive breast cancer are a marker of favourable prognosis: a study of 4,444 cases. Breast Cancer Res Treat 2008; 107:249-57; PMID:17431762; dx.doi.org/10.1007/s10549-007-9546-3
44. M.Tosolini, A.Kirilovsky, B.Mlecnik, T.Fredriksen, S.Mauger, G.Bindea, A.Berger, P.Bruneval, W.H.Fridman, F.Pages Clinical impact of different classes of infiltrating T cytotoxic and helper cells (Th1, th2, treg, th17) in patients with colorectal cancer. Cancer Res 2011; 71:1263-71; PMID:21303976; dx.doi.org/10.1158/0008-5472.CAN-10-2907
45. I.Kryczek, M.Banerjee, P.Cheng, L.Vatan, W.Szeliga, S.Wei, E.Huang, E.Finlayson, D.Simeone, T.H.Welling Phenotype, distribution, generation, and functional and clinical relevance of Th17 cells in the human tumor environments. Blood 2009; 114:1141-9; PMID:19470694; dx.doi.org/10.1182/blood-2009-03-208249
46. W.Zou, N.P.Restifo. T(H)17 cells in tumour immunity and immunotherapy. Nat Rev Immunol 2010; 10:248-56; PMID:20336152; dx.doi.org/10.1038/nri2742
47. E.M.Colin, P.S.Asmawidjaja, J.P.van Hamburg, A.M.Mus, D.M.van, J.M.Hazes, J.P.van Leeuwen, E.Lubberts. 1,25-dihydroxyvitamin D3 modulates Th17 polarization and interleukin-22 expression by memory T cells from patients with early rheumatoid arthritis. Arthritis Rheum 2010; 62:132-42.; PMID: 20039421; dx.doi.org/10.1002/art.25043
48. J.Pene, S.Chevalier, L.Preisser, E.Venereau, M.H.Guilleux, S.Ghannam, J.P.Moles, Y.Danger, E.Ravon, S.Lesaux Chronically inflamed human tissues are infiltrated by highly differentiated Th17 lymphocytes. J Immunol 2008; 180:7423-30; PMID:18490742; dx.doi.org/10.4049/jimmunol.180.11.7423
49. C.G.Hilders, L.Ras, J.D.van Eendenburg, Y.Nooyen, G.J.Fleuren. Isolation and characterization of tumor-infiltrating lymphocytes from cervical carcinoma. Int. J. Cancer 1994; 57:805-13; PMID:8206676; dx.doi.org/10.1002/ijc.2910570608